Market revenue in 2021 | USD 1,228.7 million |
Market revenue in 2028 | USD 1,178.5 million |
Growth rate | -0.6% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Loop Mediated Isothermal Amplification (LAMP) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.63% in 2021. Horizon Databook has segmented the Canada gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
Continuous research evolving around the applications of gene amplification technologies for the diagnosis of several diseases, and clinical disorders, are expected to drive the Canadian market at a significant rate.
In addition, increasing application of these technologies in screening of cell therapy products further aid in driving the market growth. Gene amplification techniques provide rapid results leading to quick treatment decisions for cell therapy recipients.
In January 2020, a group of researchers from Canada’s Michael Smith Genome Sciences Centre along with Trev and Joyce Deeley Research Centre, Terry Fox Laboratory, and Ottawa Hospital Research Institute used nucleic acid amplification techniques for Mycoplasma testing of cell therapy products.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into Canada gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account